SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
{2} Release: {1} Requests Additional Data On PULMINIQ(TM) (Cyclosporine, USP) Inhalation Solution; Agency Action Letter States That PULMINIQ Is "Approvable" But Additional Study Is Required